Long-term remission of atypical HUS with anti-factor H antibodies after cyclophosphamide pulses

Complement Factor H-Related Protein 1 Deficiency and Factor H Antibodies in Pediatric Patients with Atypical Hemolytic Uremic Syndrome

(2012) J. Hofer et al.   Clinical Journal of the American Society of Nephrology

Overall Neutralization of Complement Factor H by Autoantibodies in the Acute Phase of the Autoimmune Form of Atypical Hemolytic Uremic Syndrome

(2012) C. Blanc et al.   JOURNAL OF IMMUNOLOGY

Thrombotic microangiopathy and associated renal disorders

(2012) T. Barbour et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristics

(2012) Lianne M. Geerdink et al.   PEDIATRIC NEPHROLOGY

Alternative complement pathway assessment in patients with atypical HUS

(2011) Lubka T. Roumenina et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Pulse Cyclophosphamide Therapy and Clinical Remission in Atypical Hemolytic Uremic Syndrome With Anti–Complement Factor H Autoantibodies

(2010) Olivia Boyer et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical Phenotype

(2010) M. Noris et al.   Clinical Journal of the American Society of Nephrology

Clinical Features of Anti-Factor H Autoantibody-Associated Hemolytic Uremic Syndrome

(2010) M.-A. Dragon-Durey et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Prophylactic Eculizumab after Renal Transplantation in Atypical Hemolytic–Uremic Syndrome

(2010) Lothar Bernd Zimmerhackl et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy of Eculizumab in the Treatment of Recurrent Atypical Hemolytic-Uremic Syndrome After Renal Transplantation

(2010) Carlos Fernández-de Larrea et al.   TRANSPLANTATION

Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome

(2009) I. Moore et al.   BLOOD

Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome

(2009) C. Abarrategui-Garrido et al.   BLOOD

Clinical Practice Guidelines for the management of atypical Haemolytic Uraemic Syndrome in the United Kingdom

(2009) C. Mark Taylor et al.   BRITISH JOURNAL OF HAEMATOLOGY

The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome

(2009) M-A Dragon-Durey et al.   JOURNAL OF MEDICAL GENETICS

New Equations to Estimate GFR in Children with CKD

(2009) G. J. Schwartz et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Varicella as a trigger of atypical haemolytic uraemic syndrome associated with complement dysfunction: two cases

(2009) T. Kwon et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Functional analyses indicate a pathogenic role of factor H autoantibodies in atypical haemolytic uraemic syndrome

(2009) S. Strobel et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Eculizumab for Atypical Hemolytic–Uremic Syndrome

(2009) Jens Nürnberger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Atypical Hemolytic Uremic Syndrome Associated With Complement Factor H Autoantibodies and CFHR1/CFHR3 Deficiency

(2009) Beom Hee Lee et al.   PEDIATRIC RESEARCH

Successful pre-transplant management of a patient with anti-factor H autoantibodies-associated haemolytic uraemic syndrome

(2008) T. Kwon et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome

(2008) Gema Ariceta et al.   PEDIATRIC NEPHROLOGY